Lakefront Biotherapeutics | GLPG - 债务利息支出





债务利息支出 更改 日
argenx SE USD 1000K 172K 2026-03
AstraZeneca USD 340M 144M 2026-06
Biogen USD 72.6M 12.6M 2025-06
Genmab DKK 139M 129M 2026-06
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Incyte USD 582K 13K 2026-06
Merck EUR 137M 33M 2026-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 462M 119M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
UCB EUR 49M 29M 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12